Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment (Q42748597)

6 November 2017

title

Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment (English)

1 reference

Dominique Bonnefont-Rousselot

6 November 2017

1 reference

4

object named as

Dominique Bonnefont-Rousselot

0 references

author name string

Audrey Arfi

1

1 reference

6 November 2017

Magali Richard

2

1 reference

6 November 2017

Christelle Gandolphe

3

1 reference

6 November 2017

Patrice Thérond

5

1 reference

6 November 2017

Daniel Scherman

6

1 reference

6 November 2017

publication date

3 February 2011

1 reference

Molecular Genetics and Metabolism

6 November 2017

published in

1 reference

6 November 2017

volume

103

1 reference

6 November 2017

issue

1

1 reference

6 November 2017

page(s)

18-25

1 reference

Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Management of mucopolysaccharidosis type III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Neurodegeneration in the Niemann-Pick C mouse: glial involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Interleukin-1 is an astroglial growth factor in the developing brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Microglial secreted cathepsin B induces neuronal apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

A block of autophagy in lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Secondary accumulation of gangliosides in lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Involvement of inflammatory cytokines in central nervous system injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Infiltration of hematogenous lineage cells into the demyelinating central nervous system of twitcher mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.01.015

10.1016/J.YMGME.2011.01.015

7 January 2021

Identifiers

DOI

1 reference

6 November 2017

1 reference